 Cumberland Pharmaceuticals Inc. NASDAQ: CPIX, a specialty pharmaceutical company focused on hospital acute care and gastroenterology today provided a company update and announced first quarter 2020 financial results. Net revenues from continuing operations during the quarter were 8.3 million. Total revenues were 9.1 million, as the company recorded an additional 750,000 in revenue in the first quarter associated with divested product rights. 